National Health Investors, Inc. (NYSE:NHI) Stock Has Consensus Price Target of $81.00 According to Analysts

Shares of National Health Investors, Inc. (NYSE:NHI – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $81.00.

Several equities research analysts recently issued reports on NHI shares. Wells Fargo & Company cut their price target on National Health Investors from $78.00 to $68.00 and set an “equal weight” rating for the company in a research note on Monday, October 19th. Zacks Research raised National Health Investors from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 29th. Weiss Ratings lowered National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, September 25th. National Bank Financial set a $79.00 price objective on National Health Investors in a report on Wednesday, September 9th. Finally, BMO Capital Markets reaffirmed an “outperform” rating on shares of National Health Investors in a report on Wednesday, September 23rd.

Read Our Latest Stock Report on NHI

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Kestra Advisory Services LLC lifted its holdings in shares of National Health Investors by 5.1% during the 3rd quarter. Kestra Advisory Services LLC now owns 7,036 shares of the real estate investment trust’s stock worth $462,000 after acquiring an additional 341 shares during the period. Woodmont Investment Counsel LLC boosted its position in shares of National Health Investors by 8.6% during the 3rd quarter. Woodmont Investment Counsel LLC now owns 136,697 shares of the real estate investment trust’s stock worth $8,971,000 after acquiring an additional 10,852 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of National Health Investors by 374.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 239,542 shares of the real estate investment trust’s stock worth $15,721,000 after acquiring an additional 189,096 shares in the last quarter. Vise Technologies Inc. bought a new position in National Health Investors in the third quarter valued at approximately $458,000. Finally, Choreo LLC bought a new position in National Health Investors in the third quarter valued at approximately $223,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Price Performance

Shares of National Health Investors stock opened at $68.75 on Wednesday. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $3.38 billion, a price-to-earnings ratio of 19.87, a price-to-earnings-growth ratio of 4.36 and a beta of 0.51. National Health Investors has a twelve month low of $63.51 and a twelve month high of $91.38. The company has a 50-day simple moving average of $67.91 and a two-hundred day simple moving average of $76.31.

National Health Investors (NYSE:NHI – Get Free Report) last announced its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm had revenue of $121.32 million for the quarter. During the same quarter in the previous year, the company earned $1.22 EPS. The business’s revenue for the quarter was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Analysts forecast that National Health Investors will post 4.76 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 5.4%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors’s dividend payout ratio is 108.67%.

About National Health Investors

(Get Free Report)

National Health Investors, Inc (NYSE:NHI) is a real estate investment trust that owns and finances income-producing healthcare real estate in the United States. The company primarily focuses on properties serving older adults and patients who require specialized care.

NHI’s portfolio includes independent living communities, assisted living and memory care facilities, skilled nursing facilities, continuing care retirement communities, medical office buildings and other healthcare-related properties.

Featured Stories

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.